Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2009-10-14

Clinical Trial Update: Brain-derived Neurotrophic Factor Participates in Visceral Hyperalgesia in Irritable Bowel Syndrome (IBS) Patients

View source ↗

Summary

The update discusses a study examining brain-derived neurotrophic factor (BDNF) in visceral hyperalgesia among patients with irritable bowel syndrome (IBS).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Brain-derived neurotrophic factor (BDNF)

Snippet

Sponsor: Shandong University | Conditions: Irritable Bowel Syndrome | Status: UNKNOWN